Relationship between colorectal cancer glutathione levels and patient survival: Early results

Diseases of the Colon and Rectum

Volumn 43, Issue 8, 2000, Pages 1133-1140

  Barranco, Sam C ^a   Perry, Roger R ^b   Durm, Mary E ^a   Quraishi, Mohammed ^c   Werner, Alice L ^b   Gregorcyk, Sharon G ^b   Kolm, Paul ^b  

^a Quest Biomedical Research Center   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c Akzo Nobel Research Center Catalys   (United States)

Author keywords

Colorectal cancer; Glutathione; Prognostic factors; Survival

Indexed keywords

GLUTATHIONE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS;

EID: 0033889622     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02236562     Document Type: Article

References (27)

1. Treatment-induced changes in sensitivity in a multiclonal human tumor mixture model in vitro
2. Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro
3. Glutathione, ascorbate, and cellular protection
4. Differential sensitivities of human melanoma cells grown in vitro to arabinosylcytosine
5. Membrane-mediated drug resistance and phenotypic reversion to normal growth behavior of Chinese hamster ovary cells
6. Multidrug resistance: Molecular biology and clinical relevance
7. Relationship between glutathione levels and drug or radiation sensitivities in human gastric cell lines in vitro
8. Manipulation of cellular thiols to influence drug resistance
9. Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: Clinical and biochemical results
10. Expression of mu class glutathione S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia
11. Glutathione levels and variability in breast tumors and normal tissue
12. Intratumor variability in prognostic indicators may be the cause of conflicting estimates of patient survival and response to therapy
13. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
14. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues
15. Nonparametric estimation from incomplete observations
16. Cellular glutathione (GSH) and GSH-s-transferase (GST) activity in human ovarian tumor biopsies following exposures to alkylating agents
17. Biochemical characterization of a Mitomycin C resistant colon cancer cell line variant
18. Phase I clinical trial of intravenous L-buthionine, sulfoximine and melphalan: An attempt at modulation of glutathione
19. Glutathione levels and variability in breast tumors and normal tissue
20. Implications for therapy of drag-metabolizing enzymes in human colon cancer
21. Human ovarian tumors express gammaglutamyl transpeptidase
22. Heterogeneous responses of an in vitro model of human stomach cancer to anticancer drugs
23. Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue
24. Heterogeneity of glutathione content in human ovarian cancer
25. Measurement of thiols in cell populations from tumor and normal tissue
26. Regression analysis of prognostic factors in colorectal cancer after curative resections